NEWS RELEASES
2024
US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI) announced today it has received FDA 510k Clearance (K240297) for the Canady Helios Cold Plasma™ (CHCP) Ablation System for the ablation of soft tissue during surgery. The CHCP system consists of the...
2023
USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024
TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) are pleased to announce today a ground-breaking achievement in surgical and robotic...
Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”
The First Cold Atmospheric Plasma Phase 1 Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI) and...
USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC, announced today it has received FDA Approval for its Canady Flex RoboWrist™ to be used in open and laparoscopic procedures in...
JCRI-ABTS and USMI Reports Statistically Significant Results of the Canady Helios Cold Plasma Phase 1 Clinical Trial on Patients with Stage 4 and Recurrent Advanced Solid Tumors
TAKOMA PARK, Md.--(BUSINESS WIRE)—June 15, 2023 - The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) announced significant positive results from the first FDA Phase I IDE...
2022
2022 US Medical Innovations Raises $10.2 M in Private Placement
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a subsidiary of US Patent Innovations, LLC, announced today it has secured a $10.2 million private placement deal from multiple sources including existing partners and new investors. USMI will be...
JCRI – ABTS and USMI to Present a Two-year Follow-up of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at Israeli Society of Surgical Oncology
TAKOMA PARK, Md.--(BUSINESS WIRE)--Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) announced today that Jerome Canady MD, Chief Science Officer at JCRI-ABTS and a Surgical...
JCRI DISCOVERS REGULATORY GENE BCL2A1 FOR TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS), announced today that their recent article, BCL2A1 REGULATES CANADY HELIOS COLD PLASMA-INDUCED CELL DEATH IN TRIPLE-NEGATIVE BREAST...
2021
USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced today that the United States Patent and Trademark Office has issued a Notice of...
USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a U.S. FDA-registered life-science and biomedical device company and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced today that Jerome...
JCRI Discovers the Mechanism using Canady Helios™ Cold Plasma to Induce Cell Death in Breast Cancer
TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS), in collaboration with US Medical Innovations, LLC (USMI), announced today that they have discovered the mechanism using Canady...
USMI Developing the First Surgical Robot for Cancer Surgery
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI) announced today that it is developing the first robotic delivery system used for cancer surgery. The new Canady Surgical System (CSS) is a space-efficient, cost-effective, stand-alone solution for...
JCRI-ABTS and USMI Successfully Use Canady Helios™ Cold Plasma in Combination with FOLFIRINOX for the Treatment of Cholangiocarcinoma
TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS), LLC and US Medical Innovations, LLC (USMI) announced today that their recent article, “THE SYNERGISTIC EFFECT OF CANADY HELIOS COLD...
JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer
TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced Biological and Technological Sciences, LLC (JCRI-ABTS) and US Medical Innovations, LLC (USMI) announced today that they have successfully completed Phase 1 in their Clinical Trial...
2020
Rush Cancer Surgeons Perform Country’s First Cold Plasma Adjuvant Therapy
Clinical trial tests ionized beam of room-temperature helium gas that helps body program cancer cells for death Rush University Medical Center cancer surgeons have performed the nation’s first procedure in a clinical trial testing the cancerfighting properties of...
Canady Cold Atmospheric Plasma Provides New Insight for the Potential Treatment of Breast Cancer
TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS) in collaboration with US Medical Innovations, LLC (USMI) announced today that Canady Helios™ Cold Plasma (CHCP) has been used as an...
JCRI-ABTS Seeks FDA Emergency Use Authorization for the Canady Helios Cold Plasma HERO System for the Treatment of COVID-19
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC (USPI) announced today that the Jerome Canady Research Institute for Advanced Biological & Technological Sciences (JCRI-ABTS),...
Canady Helios Cold Plasma Scalpel Successfully Used by Chaim Sheba Medical Center Surgeons to Remove Inoperable Retroperitoneal Cancer
TAKOMA PARK, Md.--(BUSINESS WIRE)--A surgical team at The Chaim Sheba Medical Center in Tel HaShomer, Israel, with coordination by US Medical Innovations, LLC (USMI), successfully used the Canady HeliosTM Cold Plasma Scalpel (CHCPS) for a rare advanced reoccurring...
2019
US Medical Innovations Receives FDA 510(k) Clearance for the Canady Plasma Smart XL-1000 Generator
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC (USPI) announced today the U.S. Food And Drug Administration (FDA) 510(k) clearance (#K192124) to market and sell the Canady...
US Medical Innovations to Present at the Baird 2019 Global Healthcare Conference
TAKOMA PARK, MD.– US Medical Innovations, LLC (USMI), a U.S. FDA registered life science, biomedical and robotic device company (a subsidiary of US Patent Innovations, LLC), announced today that Jerome Canady MD, Chief Executive Officer, USMI will be presenting at the...
USMI and JCRI-ABTS Receive FDA Approval to Conduct the First U.S. Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Cancer
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC and the Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS)™, LLC announced today...
Canady Life Sciences Acquires French Robotic Surgical Company Endocontrol and its Voice-Operated Robotic Technology
TAKOMA PARK, Md.--(BUSINESS WIRE)--Canady Life Sciences, Inc. (A Delaware Corporation) announced today the acquisition of the French robotic company, Endocontrol (La Tronche, France). Canady Life Sciences (CLS) is a life sciences company that will consolidate US...
US Medical Innovations to Present at the JMP Securities Life Sciences Conference
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a U.S. FDA-registered life science, biomedical and robotic-device company (a subsidiary of US Patent Innovations, LLC), announced today that Jerome Canady MD, Chief Executive Officer, USMI, will be...
2018
US Medical Innovations to Present Canady Robotics SR-70™ Surgical System, the First Mini-Invasive Robotic Assisted Surgical System That Fits in the Palm of Your Hand, at the 2018 American College of Surgeons Clinical Congress
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a U.S. FDA-registered life science, biomedical and robotic device company (a subsidiary of US Patent Innovations, LLC) announced that USMI will present the Canady Robotic SR-70 Surgical System,...
Jerome Canady, M.D. Invited Speaker: The Evolution of Plasma Energy ACS Session: Energy Sources in Surgery: How to Improve Efficacy Congresso Congiunto 2018 Society of Italian Surgeons
US Patent Office Issues Decision to Grant Patent for USMI’s Cold Atmospheric Plasma for the Selective Ablation of Cancer Cells
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a U.S. FDA registered life science, biomedical and robotic device company (a subsidiary of US Patent Innovations, LLC), announced today that the United States Patent Office (USPO) has issued USPI...
US Patent Office Issues Patent for USMI’s Cold Atmospheric Plasma for the Treatment of Cancer
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a U.S. FDA registered life science and biomedical device company, and subsidiary of US Patent Innovations, LLC (USPI), announced today that the United States Patent Office (USPO) is issuing to the...
2017
Presenting the new Canady Robotic™ Surgical System and the Canady Plasma® Smart Electrosurgical Generator. Visit us in Booth #1431 at the 2017 ACS Clinical Congress in San Diego, CA at the San Diego Convention Center from October 23rd – 25th 2017
US Medical Innovations, LLC and the George Washington University Sign a $5.3 Million Agreement to Launch a New Plasma-Based Cancer Therapy Program
AKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI) announced today that its parent company, US Patent Innovations, LLC (USPI), announced today that USPI has signed a $5.3 million sponsored research agreement with the George Washington University (GW)...
GW Signs $5.3 Million Agreement to Research Plasma-Based Cancer Therapies
By Kristen Mitchell George Washington University has signed a $5.3 million corporate research sponsorship agreement with Maryland-based US Patent Innovations, LLC (USPI) that will fund a new initiative to develop biomedical applications for cold plasma technology in...
US Medical Innovations Announces Canady Helios Cold Plasma and Hybrid Plasma Scalpels Used in the First Clinical Liver Resection Performed to Remove and Selectively Kill Liver Cancer Tumor Cells
TAKOMA PARK, Md.--(BUSINESS WIRE)--A surgical team at Rush University Medical Center in Chicago, Ill., with coordination by US Medical Innovations, LLC (USMI) successfully used the Canady HeliosTM Cold Plasma Scalpel (CHCPS) for the selective killing of cancerous...
2016
Chinese Patent Office Issues Decision to Grant Patent for USMI’s Canady Hybrid Plasma™ Technology
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a biomedical device specification manufacturer and subsidiary of US Patent Innovations, LLC (USPI), announces that the People’s Republic of China (PRC) Patent Office has issued a Notification of...
Japanese Patent Office Issues Decision to Grant Patent for USMI’s Canady Hybrid Plasma™ Technology
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a U.S.-based biomedical device specification manufacturing company and subsidiary of US Patent Innovations, LLC (USPI), announces the Japanese Patent Office (JPO) decision to grant USPI’s patent...
US Medical Innovations, LLC receives ISO 13485:2003 Certification following review of the Quality Management System for USMI, PMLS, Canady Robotics and Canady Biotechnology.
2015
US Medical Innovations Announces Plans for New Robotic Surgical System
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Patent Innovations, LLC, filed for patent protection (United States Patent and Trademark Office) on the Canady RoboTM Surgical Systems with robotic surgical mini-invasive accessories. The new robotic system does not require a...
USMI receives Federal Supply Schedule Contract Approval.
Effective August 1st, 2015, the full line of US Medical Innovations products have been added to Veterans Healthcare Supply Solutions, Inc., FSS V797D-40049. Veterans Healthcare Supply Solutions, Inc., is a verified Service Disabled Veterans Owned Small Business.
Cold Plasma Used In World’s First Clinical Surgical Procedure Performed To Selectively Kill Cancer Tumor Cells
TAKOMA PARK, Md., April 16, 2015 /PRNewswire/ -- A surgical team coordinated by the US Medical Innovations, LLC (USMI) family of companies, completed the world's first clinical procedure using cold plasma for the selective killing of cancerous tissue at Baton Rouge...
Dr. Jerome Canady on Bloodless Surgery & Being a Pioneer – The Global Townhall Interview
US Patent Innovations, LLC announces Jerome Canady Research Institute receives ISO-9001: 2008 Certification
Takoma Park, M.D. – January 27, 2015 – US Patent Innovations, LLC (USPI) announced the completion of ISO-9001: 2008 certification for the Jerome Canady Research Institute for Advanced Biological and Technological Sciences, Benefit LLC (JCRI), an in-house clinical...
2014
US Medical Innovations, LLC Announces New Distribution Agreement With CrossLink Surgical, LLC
TAKOMA PARK, Md., Dec. 2, 2014 /PRNewswire/ -- US Medical Innovations (USMI), a Takoma Park, M.D. based biomedical device sales and distribution company announced today it has expanded its sales network through a distribution agreement with CrossLink Surgical...
US Patent Innovations, LLC Opens State-Of-The-Art Scientific Research Facility To Advance Uses Of Plasma Technology And Techniques In Medicine
TAKOMA PARK, Md., Nov. 14, 2014 /PRNewswire/ -- US Patent Innovations, LLC (USPI) today announced the opening of its state-of-the-art research laboratory facility, through its newest affiliate, the Jerome Canady Research Institute for Advanced Biological and...